USPTO Releases 2019 Revised Patent Subject Matter Eligibility
Background The USPTO’s 2019 Revised Patent Subject Matter Eligibility Guidance clarifies the Office’s view of what constitutes an “abstract idea,”…
Background The USPTO’s 2019 Revised Patent Subject Matter Eligibility Guidance clarifies the Office’s view of what constitutes an “abstract idea,”…
New Patent Protection Is Now Available for “Essentially Derived” Assexually Produced Plants and Hemp As of new legislation signed Decemeber…
The USPTO’s Patents for Patients program or Cancer Immunotherapy Pilot Program (“the program”) represents a good option for those looking…
Last summer, we wrote about the “Patents 4 Patients” Cancer Immunotherapy Pilot Program launched by the USPTO. At the program’s…
As part of its efforts to modernize and improve the patent filing system, the USPTO presented an overview of the…
On Friday, October 28, 2016, the Federal Register (Vol. 81, No. 209) published the USPTO’s proposed change of Rule 56…